The pharmaceutical industry recognizes a considerable boon in the narcolepsy market, driven by increased disease awareness and improved diagnostic capabilities. Despite a low prevalence rate, the consumption of therapeutic drugs to manage narcolepsy symptoms has seen a significant uptick, leading to growing profitability in the sector. However, the market remains...
Discover more insightsOne notable trend in the antipsychotic drugs sector is the growing focus on research and development (R&D). Fierce competition in the market has pushed companies to invest heavily in R&D to develop new and improved drugs. This is in response to a surge in demand, precipitated by an increase in...
Discover more insightsIn recent years, there has been substantial growth in the medication landscape for schizophrenia treatment. Notably, this trend implies an increasing demand due to higher awareness about the disease and improved diagnosis. Despite advancements, the market faces challenges such as side effects of available treatment and high relapse rates. Furthermore,...
Discover more insightsThe market for anti-epileptic drugs is characterized by significant dynamism, driven by the continuous quest for better treatment alternatives. The existing market is dominated by a mix of generic and branded drugs, with a predominantly increasing trend towards cost-effective generic drugs due to patent expiration of major brands. However, the...
Discover more insightsAntipsychotic treatments, devised mainly to cure diseases like Schizophrenia, are experiencing viral growth on a global scale. Contributing factors include increasing patient awareness, prevalence of lifestyle diseases, and escalation in geriatric disorders. Innovative R&D, aiming for novel compound discoveries, enhanced formulations and reducing side effects, is dictating the ascending trend....
Discover more insights